Alzamend Neuro, Inc. Liquidation Value
ALZN
Other
Cash & Equivalents
$2.71M
As of 2026-01-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $2.71M
Total Obligations: $0
$2.71M
Per share: $0.71
Period: 2026-01-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $2.71M
AR: $0
Total Obligations: $0
$2.71M
Per share: $0.71
Period: 2026-01-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $2.71M
AR: $0
Inventory: $0
Total Obligations: $0
$2.71M
Per share: $0.71
Period: 2026-01-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $2.71M | $0.71 |
| Liquid Liquidation Value | $2.71M | $0.71 |
| Operating Liquidation Value | $2.71M | $0.71 |
Key Components (as of 2026-01-31)
| Cash & Equivalents | $2.71M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | N/A |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 3.8M |
Explore all 50 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2026-01-31 | $2.71M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025-10-31 | $4.45M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025-07-31 | $5.62M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025-04-30 | $3.95M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes